TRPM8 and pachyonychia congenita: Conversely, PSA, acting as a transient receptor potential melastatin 8 (TRPM8) agonist, has been shown to reduce motility of the AR-negative PC3 cell line, suggesting that plasma membrane TRPM8 receptor could exert a protective role against PC progression [28].